FDA group model in R [Two-Stage / GS Designs]

posted by ElMaestro  – Belgium?, 2016-10-11 23:07 (1395 d 16:57 ago) – Posting: # 16725
Views: 28,813

Hi all,

be careful:

?lm

"The terms in the formula will be re-ordered so that main effects come first, followed by the interactions, all second-order, all third-order and so on".

So don't compare directly with any sequential anova from software that doesn't do exactly that.

I could be wrong, but...

Best regards,
ElMaestro

"Pass or fail" (D. Potvin et al., 2008)

Complete thread:

Activity
 Admin contact
20,977 posts in 4,374 threads, 1,460 registered users;
online 14 (0 registered, 14 guests [including 12 identified bots]).
Forum time: Friday 16:04 UTC (Europe/Vienna)

When someone says his conclusions are objective,
he means that they are based on prejudices
which many other people share.    Celia Green

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5